http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102416025-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41d42dda56335b56f7f1545dcbc7ca22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b048d99e6a21753c00206ca001dc4202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f670a406e9213be63f04d83c5ce563dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b276797e512e293b52957024f9c0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e328d32cb06a053728539987a2e84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3e37f3786a3b0084afba30ac0047f46
publicationDate 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102416025-B
titleOfInvention Flammulina velutipes antineoplastic active ingredient extract and its preparation method and use
abstract The invention discloses flammulina velutipes antineoplastic active ingredient extract. The preparation method of the flammulina velutipes antineoplastic active ingredient extract comprises the following steps of crushing flammulina velutipes sporophores, carrying out heating extraction by 70 to 95% of ethanol, distilling the extract to recover ethanol, dispersing the ethanol-free extract by water, carrying out extraction by a low-polarity aprotic organic solvent, and recovering the low-polarity aprotic organic solvent to obtain the flammulina velutipes antineoplastic active ingredient extract. The flammulina velutipes antineoplastic active ingredient extract contains palmitic acid, stearic acid, 9,12-octadecadienoic acid, 9,12,15-octatecatrienoic acid, ergosterol, 22,23-dihydroergosterol, ergosta-5,8,22-trien-3-ol, ergost-8(14)-en-3-ol and unknown materials. The flammulina velutipes antineoplastic active ingredient extract has obvious effects of inhibiting a human liver cancer cell HepG2 and can be utilized for preparing antineoplastic drugs. The invention also discloses a preparation method of the flammulina velutipes antineoplastic active ingredient extract.
priorityDate 2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102652742-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID341461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419595220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426132189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135768161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415791321
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID38945
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID38945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5326970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94154
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6372196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139031073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447728191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426387251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496532
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157256402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426100422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526590
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID341461

Total number of triples: 75.